Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Neuroinflammatory Changes as a Prognostic Marker in Clinically Isolated Syndromes Patients.

NCT01567553 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT01567553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01567553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Neuroinflammatory Changes as a Prognostic Marker in Clinically Isolated Syndromes Patients.
Lead sponsor
Rennes University Hospital
Phase
Observational
Overall status
Terminated
Start date
April 30, 2009
Completion date
June 30, 2015
Enrollment
37 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory disease, multiple sclerosis (ms)